Molecular Imaging Versus Biopsy
| Benefits of molecular imaging | Limitations and risks of biopsy |
| Stages cancer | Is invasive |
| Predicts response to therapy | Is restricted to accessible lesions |
| Monitors and evaluates therapeutic benefit | Has limited ability to be repeated |
| Advances personalized medicine and targeted therapy | Has risk of disseminating tumor cells |
| Images a specific biomarker (ER) | |
| Has shorter image acquisition time |